Archive: 31/05/2017
Combined modality treatment could be first course for muscle-invasive bladder cancer
A meta-analysis of previously published cancer research showed no difference in five-year and 10-year survival rates between patients who underwent radical cystectomy, which is the surgical removal of the bladder, and a bladder-preserving ...
May 31, 2017
Team improves radiation therapy for head and neck patients
Radiation therapy is one of the most common treatments used to fight cancer, with an estimated 500,000 people each year receiving radiation therapy either alone or in combination with other treatments. Patients are often ...
May 31, 2017
Personalized cell therapy combination achieves complete remission in CLL patients
Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new ...
May 31, 2017
Immunotherapy with DNA vaccine shows promise for HPV-related head and neck cancer
A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania. The treatment ...
May 31, 2017